Merger Announced
Pulmatrix and Eos SENOLYTIX merger
Announced 26 Mar 2026
Advisers
Pulmatrix
Acquirer
- Financial adviser
- Legal adviser
- Fairness opinion
Other advisers
- Financial adviser
- Target
- Eos SENOLYTIX
- Acquirer
- Pulmatrix
- Target based in
- United States
- Buyer based in
- United States
- Sector
- Biotech
- Tags
- Biotech, Drug Development
In the league tables
Similar deals
- Leyden Labs acquisition of RIGImmune Sep 2026 · Biotech
- GSK acquisition of trispecific T cell-engager (TCE) asset Sep 2026 · US$750m · Biotech
- Novo Nordisk stake in Orbis Medicines Sep 2026 · Biotech
- Eli Lilly and Company acquisition of Merida Biosciences Aug 2026 · US$2.9bn · Biotech
- Werewolf Therapeutics and Ambros Therapeutics merger Aug 2026 · US$500m · Biotech